Hematopoietic stem cell (HSC) transplantation therapy is used in the treatment of various blood disorders including leukemia, lymphoma, and sickle cell anemia. A recent review article published by Dr. Hari Maganti’s lab explores current advancements in pre-clinical research on the biology and mechanism of HSC homing and engraftment following transplantation.